Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 131Gastrointestinal Stromal Tumors 67Leukemia 66Leukemia, Myeloid, Chronic-Phase 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Blast Crisis 22Brain Neoplasms 15Philadelphia Chromosome 14Melanoma 13Sarcoma 12Neoplasms 12Neoplasm Metastasis 12Leukemia, Myeloid, Acute 12Leukemia, Myeloid, Accelerated Phase 12Glioblastoma 12Lung Neoplasms 11Prostatic Neoplasms 10Leukemia, Myeloid 9Gliosarcoma 9Glioma 8Breast Neoplasms 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Chronic 7Central Nervous System Neoplasms 7Astrocytoma 7Recurrence 6Polycythemia Vera 6Ovarian Neoplasms 6Oligodendroglioma 6Myeloproliferative Disorders 6

Interventions

liposomal doxorubicin 3Paclitaxel 3Thalidomide 2Semaxinib 2Filgrastim 2Etoposide 2Docetaxel 2Daunorubicin 2valspodar 1nirogacestat 1halofuginone 1etoposide phosphate 1entinostat 1emvododstat 1efineptakin alfa 1Valproic Acid 1Sunitinib 1Sirolimus 1Saquinavir 1SUB1 protein, human 1Ritonavir 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Palliative Care 1Nutritional Support 1Nelfinavir 1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl-2,5-dioxo-1-imidazolidinyl)butyl)-L-leucyl-N,3- dimethyl-L-Valinamide 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × AIDS-related Kaposi sarcoma × Imatinib Mesylate × Clear all
NCT00090987 2018-06-06

Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma

AIDS Malignancy Consortium

Phase 2 Completed
30 enrolled 7 charts
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡